http://topdrugs.us With reviews of the most popular tablets and online pharmacy shops Tue, 03 Aug 2010 09:04:19 +0000 http://backend.userland.com/rss092 en Several barriers prevent minority children with ADHD from receiving the most effective treatments, according to a new study by Michigan State University researchers.In the May issue of the Journal of Attention Disorders, the researchers argue schools and communities should do a better job of getting information to minority families about ... http://topdrugs.us/minorities-face-barriers-to-effective-adhd-treatments-msu-study-contends/ A major study of more than a million children has found strong links between receiving medication for attention deficit hyperactivity disorder (ADHD) and limited maternal education, single parent families and welfare benefits, according to the June issue of Acta PaediatricaSwedish experts teamed up to carry out what they believe is ... http://topdrugs.us/link-between-adhd-low-maternal-education-lone-parents-and-welfare-benefits/ Parents looking to get their kid's attention - or keeping them focused at home and in the classroom - should try to limit their television viewing and video game play. That's because a new study led by three Iowa State University psychologists has found that both viewing television and playing ... http://topdrugs.us/tv-viewing-video-game-play-contribute-to-kids-attention-problems/ Teens with attention-deficit/hyperactivity disorder (ADHD) - the most common childhood psychiatric condition in the United States - are less likely to finish high school on time than students with other mental-health disorders that often are considered more serious, a large national study by researchers at the UC Davis School of ... http://topdrugs.us/top-of-the-list-for-dropping-out-of-high-school-adhd-conduct-disorder-and-smoking/ A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.The research findings have just been published online in the international Journal of Attention Disorders.Leader of Nutrition studies at the Institute, Associate Professor Wendy Oddy, said the study examined ... http://topdrugs.us/link-between-western-diet-and-adhd/ The Washington, D.C., health department has launched a campaign to promote use of the female condom as a way to help curb the spread of HIV in the city, the AP/Atlanta Journal-Constitution reports. A 2009 study found that about 3% of the city's population over age 12 is HIV-positive. According ... http://topdrugs.us/dc-health-dept-pushes-female-condoms-in-hiv-outreach-initiative/ Many parents wonder how to handle a child who has been diagnosed with ADHD, anxiety or depression - or even one who is struggling with day-to-day stress. In her new book, Mental Health, Naturally: The Family Guide to HolisticCare for a Healthy Mind and Body (American Academy of Pediatrics, March ... http://topdrugs.us/mental-health-naturally-first-of-its-kind-comprehensive-guide-to-nonprescription-therapies-for-mental-and-physical-well-being/ Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal ... http://topdrugs.us/targacept-initiates-phase-2-study-of-tc-5619-in-attention-deficithyperactivity-disorder-in-adults-2/ The Journal of Neurotherapy announces the publication of "A Position Paper on Neurofeedback for the Treatment of ADHD," in which the authors demonstrate that neurofeedback is a safe and efficacious treatment intervention for AD/HD, meeting a rating level of 5: Efficacious and Specific. The issue 14(2) of the journal is ... http://topdrugs.us/the-journal-of-neurotherapy-announces-neurofeedback-to-be-an-efficacious-and-specific-modality-for-the-treatment-of-adhd/ Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is ... http://topdrugs.us/fda-approves-daytrana%c2%ae-methylphenidate-transdermal-system-cii-for-the-treatment-of-adhd-in-adolescents/